The first national iodine survey conducted in Israel has revealed a high burden of iodine deficiency among Israelis, posing a high risk of maternal and fetal hypothyroidism and impaired neurological development of the fetus in Israel.
Adequate iodine intake is essential for thyroid function and human health throughout life. Even mild iodine deficiency might prevent children from attaining their full intellectual potential, and mild to moderate ID has been linked with decreased cognitive performance. Iodine deficiency in utero and in early childhood impairs brain development, and severe iodine deficiency causes cretinism (physical malformation, dwarfism and mental retardation) and goiter (the enlargement of the thyroid gland).
The research findings were presented at The 46th Annual Meeting of the Israel Endocrine Society, which took place on March 20-21 in Ramat Gan.
The International Child Development Steering Group has identified iodine deficiency (ID) as a key global risk factor for impaired child development, and the World Health Organization’s recommends routine monitoring of population-based data on urinary iodine every five years as a means of sustainable elimination of ID. Yet Israel is among the few countries that have never performed a national iodine survey, and does not provide iodine prophylaxis, even though some of its population has suffered from ID in the past. Israel similarly lacks current data on the incidence and prevalence of thyroid disease.
Now, researchers from the Hebrew University of Jerusalem, and their colleagues at Maccabi Healthcare Services and Barzilai University Medical Center in Ashkelon in Israel, and ETH Zurich in Switzerland, with support of the Iodine Global Network, have obtained the first nationally representative data about iodine status in the Israeli population. To do this, they collected pre-discard spot-urine samples, from 1,023 school-age children and 1,074 pregnant women, representing all regions and major sectors in Israel (Arab, Jewish secular and orthodox), during 2016 at the Maccabi Healthcare Services (MHS) central laboratory.
They found a high burden of iodine deficiency in the general population: 62% of school-age children and 85% of pregnant women fall below the WHO’s adequacy range.
The median urinary iodine concentration (UIC) among Israel’s pregnant women, only 61 micrograms iodine/liter and for school-age children, the median of 83 micrograms/liter, suggest that the iodine status in Israel is among the lowest in the world. Iodine adequacy is defined by the WHO as a population median of 150-249 micrograms/liter for pregnant women and 100-199 micrograms/liter for school-age children. Virtually no differences were seen between different ethnicities and regions of the country suggesting that low iodine status is widespread and universal throughout the country.
According to the researchers, the high burden of iodine insufficiency in Israel is a serious public health and clinical concern. By comparison to data from other countries with a similar extent of deficiency, these data suggest that there is a high risk of maternal and fetal hypothyroidism and impaired neurological development of the fetus in Israel. By extrapolation, given the rate of insufficiency in Israeli pregnant women, nearly all pregnant women and their children may be at risk, implying that the majority of the population could be unlikely to realize its full intellectual potential.
“The immediate implication of our findings is that we need to improve the public’s intake of iodine,” said Prof. Aron Troen, Principal Investigator at the Nutrition and Brain Health Laboratory, School of Nutrition Science, Hebrew University’s Robert H. Smith Faculty of Agriculture, Food and Environment. “It seems that as in most other countries, Israel’s food supply and our collective dietary habits do not ensure iodine sufficiency. Thus eliminating iodine deficiency and achieving optimal iodine status in Israel’s population will require a sustainable, government-regulated program of salt or food iodization. The costs are small and the benefits substantial and have been proven in over 160 countries around the world where this is done.”
Until now, isolated but persistent calls to address this issue have not translated to action, perhaps due to lack of awareness, or the unfounded but widespread belief that Israel’s proximity to the sea likely prevents ID, leading to a corresponding lack of political will.
However, in the absence of a universal salt iodization program, and in light of the heavy national reliance on iodine-depleted desalinated seawater as drinking and irrigating water, the study’s results point to a major national public health problem.
According to the researchers, a universal salt iodization and monitoring program should be urgently initiated. Dr. Jonathan Arbelle, lead co-investigator from Maccabi Healthcare Services, who presented the findings at the meeting, called upon the Israel Endocrine Society to develop guidelines for clinical practitioners who care for pregnant and lactating women. “Caregivers should recommend adequate iodine intake during pregnancy and lactation, and a randomized clinical trial of risk and benefit for correction of mild-moderate iodine deficiency during pregnancy must be considered,” said Dr. Arbelle.
“A healthful diet is a foundation of a prosperous nation. The public has a right, and government has both a moral obligation and clear-cut social and economic incentive to ensure that the nation’s food supply supports the public’s health, well-being and productivity,” said Prof. Troen.
Yaniv Ovadia, the doctoral student and registered dietitian who performed the study, said, “Individuals can improve their iodine status through increased consumption of iodine-rich foods such as milk, dairy and salt water fish. They can also replace regular table salt with iodized salt.” However, only a small fraction of the salt sold in Israel is iodized, and it is sold at a much higher price than regular salt, although it does not need to be. The World Health Organization and Iodine Global Network encourage mandatory, universal salt iodization, including the all discretionary household salt. However, some countries have effectively been able to increase their iodine intakes through the use of iodized salt in processed foods, including bread and condiments, and this may be considered in Israel. “Government action is needed to ensure that everyone has access to iodized salt, added Prof. Troen.
These findings also highlight the critical need for routine public health surveillance, not only of iodine, but also of other nutritional and environmental exposures that determine the Israeli population’s collective health.
“I’m pleased that the Ministry of Health has been supportive of this particular research effort, but to act on the findings and make a sustainable change will require government funding and legislation,” said Prof. Troen.
The research team included doctoral student Yaniv Ovadia, Varda Nadler, Hadassa Brik, Tamar Wolf, Michael Zimmermann, Sandra Weibel, Dov Gefel, Jonathan Arbelle, and Aron Troen.
Participating institutions included the Nutrition and Brain Health Laboratory, Institute of Biochemistry, Food Sciences, and Nutrition, Robert H Smith Faculty of Agriculture, Food and Environment, Hebrew University of Jerusalem, Israel; Department of Internal Medicine “C”, Barzilai Medical University Center, Israel; Central Laboratory, Maccabi Healthcare Services, Israel; and the Human Nutrition Laboratory, Department of Health Sciences and Technology, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland.
The Hebrew University Nutrition and Brain Health Laboratory is a partner in EUthyroid, an EU-funded research project to evaluate current national efforts aimed at preventing iodine deficiency disorders, which aims to provide the basis to develop appropriate measures for harmonizing and improving iodine intake in cooperation with national authorities.
The research was supported by grants from the Medical Research and Development Fund for Health Services – Jerusalem, and the Israel Ministry of Health Chief Scientists Office, with partial funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634453, “EUthyroid”, and funding to the ETH Zurich iodine laboratory from the Iodine Global Network.